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Abstract
The fibroblast growth factor and receptor system (FGF/FGFR) mediates cell communication and pattern formation in many
tissue types (e.g., osseous, nervous, vascular). In those craniosynostosis syndromes caused by FGFR1-3 mutations, alteration
of signaling in the FGF/FGFR system leads to dysmorphology of the skull, brain and limbs, among other organs. Since this
molecular pathway is widely expressed throughout head development, we explore whether and how two specific
mutations on Fgfr2 causing Apert syndrome in humans affect the pattern and level of integration between the facial
skeleton and the neurocranium using inbred Apert syndrome mouse models Fgfr2
+/S252W and Fgfr2
+/P253R and their non-
mutant littermates at P0. Skull morphological integration (MI), which can reflect developmental interactions among traits by
measuring the intensity of statistical associations among them, was assessed using data from microCT images of the skull of
Apert syndrome mouse models and 3D geometric morphometric methods. Our results show that mutant Apert syndrome
mice share the general pattern of MI with their non-mutant littermates, but the magnitude of integration between and
within the facial skeleton and the neurocranium is increased, especially in Fgfr2
+/S252W mice. This indicates that although
Fgfr2 mutations do not disrupt skull MI, FGF/FGFR signaling is a covariance-generating process in skull development that
acts as a global factor modulating the intensity of MI. As this pathway evolved early in vertebrate evolution, it may have
played a significant role in establishing the patterns of skull MI and coordinating proper skull development.
Citation: Martı ´nez-Abadı ´as N, Heuze ´ Y, Wang Y, Jabs EW, Aldridge K, et al. (2011) FGF/FGFR Signaling Coordinates Skull Development by Modulating Magnitude
of Morphological Integration: Evidence from Apert Syndrome Mouse Models. PLoS ONE 6(10): e26425. doi:10.1371/journal.pone.0026425
Editor: Gary Stein, University of Massachusetts Medical School, United States of America
Received August 4, 2011; Accepted September 26, 2011; Published October 28, 2011
Copyright:  2011 Martı ´nez-Abadı ´as et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: National Institutes of Craniofacial and Dental Research (NIDCR), National Institutes of Health (NIH): R01DE018500 and 3R01DE018500-02S1. Comissionat
per a Universitats i Recerca (CUR), Generalitat de Catalunya, Spain: 2008 BP A 00170. The funders had no role in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jtr505@gmail.com
Introduction
Fibroblast growth factors (FGFs) and their receptors (FGFRs)
play significant roles in vertebrate organogenesis and morphogen-
esis by controlling levels of cell proliferation, differentiation,
migration, adhesion and death [1,2]. Misregulation can lead to
severe dysmorphogenesis and disease, as in the case of the FGFR-
related craniosynostosis syndromes (e.g. Apert, Crouzon, Muenke,
and Pfeiffer syndromes), which have a prevalence of 6–7 per
100,000 live births and are caused by mutations on FGFR1, 2 and
3. Craniosynostosis syndromes are traditionally characterized by
premature fusion of cranial vault sutures, but malformations are
widespread, affecting other aspects of the skull, as well as other
bodily systems (i.e., brain, limbs, heart, and lung) [3].
More than 98% of cases of Apert syndrome are caused by two
dominant mutations involving adjacent amino acids on FGFR2,
Ser252Trp (S252W) and Pro253Arg (P253R) [4]. These gain-of-
function mutations alter the ligand-binding affinity and specificity
of the receptors affecting molecular signaling involved in the
development of different tissues including bone [5]. Analysis of the
Fgfr2
+/S252W and Fgfr2
+/P253R Apert syndrome mouse models has
shown that Fgfr2 mutations cause primary dysmorphologies of the
facial skeleton, the cranial vault, the cranial base, and the brain
[6–9]. FGF ligands and their receptors are differentially expressed
in these cranial regions and tissues mediating cell communication
and interaction [10], so it is likely that besides malformations
within each structure, altered expression of FGF/FGFR signaling
may lead to changes in anatomical relationships among skull
regions. Such changes can be evaluated by the comparative
analysis of patterns of morphological integration [11].
Morphological integration (MI), assessed by statistical analysis of
covariance patterns between phenotypic traits, can reflect genetic,
developmental or functional interaction among traits [12].
Biologically, covariation patterns precisely define the interdepen-
dence among biological structures. Since MI patterns can facilitate
or prevent morphological evolution in certain directions of shape
change [12], we propose that conserved MI patterns could
constrain clinically relevant shape changes induced by the disease
process. The combination of mutation-induced change and
conserved MI patterns might provide a mechanism whereby final
morphology is altered but maintains a viable and functional shape.
Changes in the magnitude of MI alter the degree by which
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Here we explore the potential role of FGF/FGFR signaling in
contributing to patterns and magnitude of skull MI using Fgfr2
+/
S252W and Fgfr2
+/P253R Apert syndrome mouse models and their
non-mutant littermates.
The critical importance of FGF/FGFR signaling in the
appearance of the vertebrate head [13], as well as its role in the
development of many cranial tissues prompts us to explore
whether the FGF/FGFR pathway is a covariance-generating
process at the level of skull phenotypes. The main developmental
determinants of the covariation pattern of the mammalian skull
are not yet identified and to date few studies have tested whether,
how and to what extent the effect of single gene mutations on
specific developmental pathways and/or cellular signaling can
alter the covariation structure using controlled experimental data
[14–16]. Our previous analyses showed that despite coronal
craniosynostosis in mice carrying Fgfr2 Apert syndrome mutations,
at P0 the facial skeleton is the most affected region of the skull with
phenotypic differences between Fgfr2
+/S252W and Fgfr2
+/P253R
mutant mice restricted to the posterior aspect of the palate [9].
By exploring how the two Fgfr2 mutations that cause Apert
syndrome in humans affect morphological integration patterns in
the mouse skull, we will reveal the relationship between the facial
skeleton and the neurocranium in mutant mice relative to their
non-mutant littermates and how changes in this interdependence
affect skull dysmorphology of Apert syndrome mouse models.
To test whether the two Apert syndrome Fgfr2 mutations alter
the covariation structure of the skulls of mutant mice relative to
their non-mutant littermates, and whether the effects of these
mutations on MI patterns are similar, we use geometric
morphometric analysis of 3D landmark data collected from the
newborn (P0) skulls of Fgfr2
+/S252W and Fgfr2
+/P253R Apert
syndrome mouse models [6,7]. Our main goal is not to identify
the morphological modules of the mouse skull, but to determine
whether the Fgfr2 Apert syndrome mutations alter a specific
pattern of skull MI and thus infer if the FGF/FGFR signaling
contributes to patterns of integration of the head. Our null
hypothesis (Ho) is that the skulls of Apert syndrome mouse models
(Fgfr2
+/S252W and Fgfr2
+/P253R) and their non-mutant littermates
have similar covariance patterns and magnitude of integration. We
test this hypothesis through the statistical comparison of
covariance patterns and magnitudes within the facial skeleton
(face) and neurocranium and between these two anatomical
regions. If the null hypothesis cannot be rejected, then FGF/
FGFR signaling has no effect on MI patterns. If differences in
either the pattern or magnitude of MI are found, then Ho is
rejected and the alternative hypothesis (H1) indicates that the
FGF/FGFR signaling affects patterns of MI of the skull. The Fgfr2
mutations present in these mice could alter the covariation
structure in three plausible ways: H1A) MI is changed in both
pattern and magnitude, resulting in different covariance structures
in mutant and non-mutant mouse skulls; H1B) MI pattern is
maintained but the magnitude is altered resulting in similar
patterns but different magnitudes of integration in mutant and
non-mutant mice; and H1C) MI pattern is altered but magnitude
of integration remains unchanged.
Materials and Methods
Ethics statement
Mice were generated, euthanized, fixed and imaged in
compliance with animal welfare guidelines approved by the Johns
Hopkins University, the Mount Sinai School of Medicine, and
Pennsylvania State University Animal Care and Use Committees.
Shape analysis
Our sample consisted of 100 newborn mice bred on C57BL/6J
genetic background for 20 generations. Further details on
generation of targeting construct have been previously published
[6,7].
Micro CT (mCT) scans of the heads of Fgfr2
+/S252W and
Fgfr2
+/P253R mutant mice and their non-mutant littermates at P0
were acquired by the Center for Quantitative Imaging at the
Pennsylvania State University (www.cqi.psu.edu) using the HD-600
OMNI-X high-resolution X-ray computed tomography system
(Bio-Imaging Research Inc, Lincolnshire, IL). Pixel sizes range from
0.015 to 0.020 mm, and slice thickness from 0.016 to 0.025 mm.
Isosurfaces were reconstructed to represent all cranial bone at P0
usingthesoftwarepackageAvizo6.0(Visualization SciencesGroup,
VSG). Based on hydroxyapatite phantoms imaged with the
specimens, the minimum thresholds used to create isosurfaces
ranged from 70 to 100 mg/cm
3 partial density of hydroxyapatite. A
set of 16 three-dimensional (3D) landmarks from the left side of the
skull (Fig. 1) was collected from the isosurfaces. Each specimen was
digitized twice by the same observer and measurement error was
minimized by averaging the coordinates of the two trials. The
maximum accepted measurement error was 0.05 mm. Landmark
definitions can be found in Table S1.
To obtain comparable results across groups and across anatomical
regions [17], equal sample sizes were used for each group (N=25)
and the shapes of the facial skeleton and the neurocranium were
defined using equally sized subsets of mutually exclusive landmarks
(K=8 for each anatomical region) (Fig. 1). Preliminary analyses with
a larger number of landmarks, including more landmarks on the
rostral aspects of the facial skeleton, the cranial vault and cranial base
support the results presented here [18].
Pattern and magnitude of integration between the facial
skeleton and the neurocranium
We quantified the integration between the face and the
neurocranium and produced visualizations of the patterns of
associated shape changes between these two regions using Two-
Block Partial Least Squares analysis (PLS) [19], which performs a
singular value decomposition of the covariance matrix. Uncorre-
lated pairs of new axes are derived as linear combinations of the
original variables, with the first pair accounting for the largest
amount of inter-block covariation, the second pair for the next
largest amount and so on [19]. The amount of covariation is
measured by the RV coefficient, which is a multivariate analogue
of the squared correlation [20]. Statistical significance was tested
using permutation tests under the null hypothesis of complete
independence between the two blocks of variables.
Comparison of patterns and magnitude of MI among
Fgfr2
+/S252W and Fgfr2
+/P253R mutant mice and their non-mutant
littermates required PLS analyses of varying subsets of individuals
including: 1) all mutant and non-mutant mice, 2) only non-mutant
mice, 3) only mutant mice, 4) Fgfr2
+/S252W mutant mice and their
non-mutant littermates, 5) Fgfr2
+/P253R mutant mice and their
non-mutant littermates. Each PLS analysis was applied to the
adjusted coordinate data obtained from two separate Procrustes
fits (one for the facial landmarks and another for the neurocranial
landmarks). Procrustes fits were performed separately for each
PLS analysis. General Procrustes Analysis (GPA) is a procedure
that superimposes configurations of landmarks by shifting them to
a common position, rotating and scaling them to a standard size
until a best fit of corresponding landmarks is achieved [21].
Because the covariance matrix as estimated by GPA is neither
invariant nor identifiable [22] we have estimated the covariance of
the face and the neurocranium separately, and together as a
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results of our analyses using varying sets of landmarks in additional
analyses shown in Supporting Information S1.
As size affects the whole skull and can inflate measures of
integration [20], we explored the effect of allometry by computing
a multivariate regression of shape [23] on centroid size, measured
as the square root of the summed distances between each
landmark coordinate and the centroid of the landmark configu-
ration [21]. To adjust for size-shape differences we repeated all the
PLS analyses using the residuals of the multivariate regression.
To statistically compare the covariance matrices across Fgfr2
+/S252W
and Fgfr2
+/P253R Apert syndrome mouse models and their non-mutant
littermates, we computed two-by-two matrix correlation tests between
the covariance matrices of: 1) Fgfr2
+/+ non-mutant mice of both
models; 2) Fgfr2
+/S252W and Fgfr2
+/P253R mutant mice; 3) Fgfr2
+/S252W
and their non-mutant littermates, 4) Fgfr2
+/P253R mutant mice and their
non-mutant littermates. For each analysis, a matrix permutation test
against the null hypothesis of complete dissimilarity of the covariance
matrices was performed by permuting landmarks and including the
diagonals of the covariance matrices after 10,000 randomization
rounds. All analyses were performed using MorphoJ [24].
Finally, we computed the variance of the eigenvalues (EV) [25] as an
alternative metric of overall integration between the face and
neurocranium, as well as to quantify and compare the magnitude of
integration within the face and the neurocranium across mouse groups.
In poorly integrated structures where correlations between variables
are weak, variance will be distributed across many eigenvectors,
resulting in low EV. Conversely, in highly integrated structures where
correlations are high, variance will be concentrated in few eigenvectors,
resulting in high EV scores [25]. We computed the variance-
covariance matrices of the Procrustes coordinates of the face (K=8),
the neurocranium (K=8) and the whole skull (face+neurocranium,
K=16) for each group separately. From each variance-covariance
matrix we computed the eigenvalues and obtained ranges of EV
integration values by resampling each dataset with replacement for
1,000 iterations. To compare the integration measures across groups
and remove variation in the index caused by the magnitude of the
overall variance we standardized the EV scores by the total shape
variance within the entire sample group following Young [26]. These
procedures were calculated using the PopTools plug-in for Excel
version 3.2 (http://www.poptools.org).
Results
Patterns of skull MI are not disrupted by Apert syndrome
Fgfr2 mutations
The pooled PLS analysis including all mice was used to test
whether Apert syndrome Fgfr2 mutations alter the normal pattern
Figure 1. Landmarks collected from mCT reconstructions of P0 mouse skulls. Top: Left lateral view, superior endocranial view with vault
removed and inferior view with mandible removed. Bottom: Wireframes used in Fig. 3 to display shape changes of the facial configuration of
landmarks (blue) and the neurocranial configuration of landmarks (red). Codes and landmark definitions can be found in Table S1 and at our website
http://getahead.psu.edu/LandmarkNewVersion/P0mouseskull_updated_applet.html.
doi:10.1371/journal.pone.0026425.g001
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axes (PLS1) explains 96.2% of the total covariance (Fig. 2A) and
that the overall strength of association between the facial skeleton
and the neurocranium is high (RV=0.72) and statistically
significant (Table 1). Distribution of specimens along the first pair
of PLS axes displays a separation into two groups, reflecting the
morphological differences between mice carrying the Fgfr2
mutations (negative PLS1 values) and their non-mutant littermates
(positive PLS1 values) (Fig. 2A). Non-mutant littermates from both
models completely overlap, whereas Fgfr2
+/S252W and Fgfr2
+/P253R
mutant mice only partially overlap, with Fgfr2
+/S252W mutant mice
showing an extended range of covariation (Fig. 2A).
The multivariate regression of skull shape on centroid size
showed that size significantly predicts 29.33% of total shape
variation (P-value,0.0001). The separation between mutant and
non-mutant mice disappears (Fig. 2B) and the RV coefficient is
reduced (RV=0.39; Table 1) when allometry is adjusted for,
indicating that size is a common factor affecting the facial skeleton
and the neurocranium thereby inflating integration measures.
Nevertheless, PLS1 still explains a very high percentage of the total
covariance (90.3%; Table 1), showing that a single pair of PLS
axes, shared by mice carrying these Fgfr2 Apert syndrome
mutations and their non-mutant littermates, explains nearly all
covariation between the facial skeleton and the neurocranium.
This indicates that Apert syndrome mouse models and their non-
mutant littermates have similar covariance patterns.
The matrix correlation analyses confirmed that Fgfr2
+/S252W
and Fgfr2
+/P253R mutant mice and their non-mutant littermates
have similar covariation structures. The matrix correlation values
obtained between groups were: 1) Fgfr2
+/+ non-mutant mice of
both models: r=0.69, p,0.0001; 2) Fgfr2
+/S252W and Fgfr2
+/P253R
mutant mice: r=0.49, p,0.0001; 3) Fgfr2
+/S252W and their non-
mutant littermates: r=0.60, p,0.0001; 4) Fgfr2
+/P253R mutant
mice and their non-mutant littermates: r=0.47, p,0.0001. The
two-by-two comparisons of the covariance matrices always
provided high and significant matrix correlation values, and
therefore the statistical null hypothesis of complete dissimilarity
between covariance matrices was rejected, providing further
support for similarity of covariance matrices between Apert
syndrome mouse models and their non-mutant littermates.
Figure 2. Scatterplots of PLS1 scores of the facial and the neurocranial skeleton using varying subsets of individuals. A) PLS analysis
including Apert syndrome mouse models and non-mutant littermates before adjusting for allometry; B) PLS analysis including Apert syndrome
mouse models and non-mutant littermates after adjusting for allometry; C) PLS analysis of non-mutant littermates after adjusting for allometry; D) PLS
analysis of mutant Apert syndrome mouse models after adjusting for allometry.
doi:10.1371/journal.pone.0026425.g002
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Apert syndrome mouse models
To determine whether the FGF/FGFR signalling pathway
modulates the intensity of established patterns of skull integration,
we compared the magnitude of MI between face and neurocra-
nium by comparing the RV coefficient of the PLS analysis of non-
mutant mice with the RV coefficient of the PLS estimated for
mutant mice.
Scatterplots of the PLS analysis of non-mutant littermates from
both models show complete overlap before (data not shown) and
after removing allometry (Fig. 2C). Size significantly predicted
10.79% of shape variation (P-value,0.0001) and the PLS results
showed that the total percentage of covariation between the face
and the neurocranium is moderate in non-mutant mice (34.7%;
Table 1). The PLS analysis of non-mutant mice provided a low but
significant measure of overall integration between the face and the
neurocranium (RV=0.19). When allometry was statistically
removed, the RV was reduced and no longer significant,
indicating some degree of independence between the face and
the neurocranium in non-mutant mice (Table 1). However,
modularity testing of the face and the neurocranium in non-
mutant mice did not confirm this result (Supporting Information
S1 and Fig. S1).
The PLS of Fgfr2
+/S252W and Fgfr2
+/P253R mice reveal two
separate clusters that are distributed along the same PLS1 axes
(Fig. 2D). Size only predicted 3.41% of total shape variation (P-
value=0.12) in mutant Apert syndrome mice and the PLS results
were very similar before (data not shown) and after removing
allometry (Fig. 2D), showing a high total percentage of covariation
between the facial skeleton and the neurocranium (70%; Table 1).
The RV coefficient estimated for the mutant mice was twice as
large (RV=0.40) as that estimated for the non-mutant littermates
(Table 1). Though the covariance patterns of Apert syndrome
mouse models and their non-mutant littermates are similar, our
results show that Apert syndrome mouse models differ from their
non-mutant littermates in magnitude of MI, which leads to
rejection of Ho and provides support for H1B.
Apert syndrome Fgfr2 mutations alter skull MI with
differing magnitude
Two separate PLS analyses, each comparing one of the mutant
groups (Fgfr2
+/S252W and Fgfr2
+/P253R) with their respective non-
mutant littermates, were used to determine the effect of each
mutation on normal patterns of morphological integration (Fig. 3A,
B). Shape patterns of MI between the facial skeleton and the
neurocranium are very similar in Fgfr2
+/S252W and Fgfr2
+/P253R
mutant mice relative to their respective non-mutant littermates
(Fig. 3A, B). In both Apert syndrome mouse models (negative
PLS1 values) and their non-mutant littermates (positive PLS1
values), covariation between the face and the neurocranium is
mainly driven by associated changes in the posterior aspects of the
facial skeleton and the palate and the anterior cranial base (Fig. 3A,
B). In Fgfr2
+/S252W and Fgfr2
+/P253R mutant mice, the zygomatic
bone is located more anteriorly and the posterior edge of the
horizontal plate of the palatine bone is shifted postero-medially.
The associated neurocranial change is a posterior shift in the
position of the presphenoid that affects cranial base flexion and the
relative positioning of the facial skeleton. Moreover, in mutant
Apert syndrome mouse models the neurocranium is shortened and
widened, resulting in the typical brachycephalic shape traditionally
associated with premature closure of the coronal suture.
Both PLS analyses showed that the first pair of PLS axes (PLS1)
explained a high percentage of total covariation and that RV
coefficients were high and significant (Table 1, Fig. 3A, B).
However, the magnitude of association between the face and
neurocranium in Fgfr2
+/S252W mutant mice and their non-mutant
littermates is higher (RV=0.51) relative to that of the Fgfr2
+/P253R
mutant mice and their non-mutant littermates (RV=0.40). Also,
Fgfr2
+/S252W mutant mice and their non-mutant littermates are
clearly differentiated along the first pair of PLS1 axes showing no
overlap (Fig. 3A), whereas Fgfr2
+/P253R mutant mice and their non-
mutant littermates overlap with individuals continuously distrib-
uted along the first pair of PLS1 axes (Fig. 3B). Analyses including
the allometric components of shape provided very similar results
(data not shown).
Increased integration within and between the facial
skeleton and the neurocranium in Apert syndrome
mouse models, especially in Fgfr2
+/S252W
The variance of the eigenvalues confirmed that the pattern of
MI is not disrupted in mutant Apert syndrome mouse models in
comparison with their non-mutant littermates. Analyses of all four
groups show that of the two regions the neurocranium is the most
integrated; and that the integration within regions is higher than
integration between regions. This analysis also indicates that the
magnitude of MI within and between regions is increased in mice
carrying the Fgfr2 mutations, especially the S252W mutation
(Fig. 4), confirming all previous results and supporting H1B.
Discussion
Extensive research has shown that cranial integration is highly
conserved across placental mammals [27,28] and that this shared
pattern of skull covariation can be preserved even under genetic
and developmental alterations [29,30], disease [31], and cultural
deformation practices [32]. That MI of the vertebrate skull is
Table 1. Results of PLS analyses.
Samples used RV coefficient P-value % Total Cov PLS1 Corr PLS1 P-value
All groups 0.72 (0.39) 0.0001 (0.0001) 96.2% (90.3%) 0.92 (0.75) 0.0001 (0.0001)
Both NON-MUT 0.19 (0.16) 0.0364 (0.3312) 56.9% (34.7%) 0.60 (0.57) 0.0314 (0.5745)
Both MUT 0.40 (0.36) 0.0001 (0.0001) 70.0% (69.4%) 0.82 (0.77) 0.0001 (0.0001)
252 NON-MUT/MUT 0.83 (0.51) 0.0001 (0.0001) 96.2% (91.4%) 0.94 (0.74) 0.0001 (0.0001)
253 NON-MUT/MUT 0.71 (0.40) 0.0001 (0.0001) 97.1% (84.8%) 0.93 (0.77) 0.0001 (0.0001)
For each grouping we provide the RV coefficient of overall integration between the face and the neurocranium and associated P-value; the percentage of total
covariation explained by PLS1 axes; the correlation score between facial and neurocranial PLS1 scores and associated P-value. Values in parentheses correspond to
results obtained after adjusting for allometric effects.
doi:10.1371/journal.pone.0026425.t001
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in cranial shape across species and populations are more
commonly associated with changes in magnitude rather than in
pattern of MI [28]. Our results confirm that despite severe
craniofacial dysmorphologies, mice carrying Apert syndrome
Fgfr2 mutations share MI patterns with their non-mutant
littermates, but show increased integration (Table 1 and Figs. 2,
3, 4), providing evidence to reject Ho and support H1B. Thus, our
results indicate that the FGF/FGFR signaling system may
contribute to the covariance-generating processes operating
within skull development by adjusting the magnitude of MI
patterns.
Figure 3. PLS analyses among each Apert syndrome mouse model and their non-mutant littermates after removing allometry. A)
Fgfr2
+/S252W and non-mutant littermates; B) Fgfr2
+/P253R and non-mutant littermates. Associated facial and neurocranial shape changes corresponding
to the first pair of PLS1 axes show similar skull MI patterns between the two models. Orange wireframes display face and neurocranium shape
changes associated with positive and negative values of PLS1 in comparison to mean shape PLS1 values (grey dashed wireframe). For anatomical
correspondence see Fig. 1. Note that all landmarks cannot be seen from a single skull view and we chose to display the inferior view of the skull
because main shape changes occur in the palate and the anterior aspect of the neurocranium.
doi:10.1371/journal.pone.0026425.g003
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morphological integration
Our analysis provides another type of evidence for the
important role of FGF/FGFR signaling pathways as a global
factor in coordinating skull growth. FGF/FGFR signaling interacts
with other major signaling pathways that regulate chondrogenesis
and osteogenesis [1] and directly affects osteoprogenitor, osteo-
genic, as well as other cell types. The changes induced by FGF/
FGFR signaling (e.g., differentiation, proliferation, adhesion,
apoptosis) have significant effects on the morphology of developing
bone, but also have a significant global influence on proper
coordination among different regions of the growing skull.
Recently it has been shown that alteration of FGF signaling for
somitogenesis during gastrulation in early vertebrates may have
led to the creation of an anterior region with unsegmented
paraxial mesoderm and the appearance of the ‘‘new head’’ [13].
Our results add additional evidence to the key role of FGF/FGFR
signaling in the development of the skull and suggest a potential
role in the maintenance of established MI patterns in the evolution
of the vertebrate head.
Altered balance of FGF/FGFR signaling in Apert syndrome
mouse models not only produces widespread primary dysmor-
phologies [6–9], but also modification of the magnitude of
integration among cranial structures (Table 1, Fig. 4), which
may explain further secondary dysmorphogenesis in craniosynos-
tosis syndromes. In our Apert syndrome mouse models we have
found that both the facial skeleton and the neurocranium are
primarily affected by the Fgfr2 mutations [9], and that the MI
patterns are conserved, but the magnitude of integration between
the face and the neurocranium is increased. Preliminary analyses
based on reduced samples of Apert syndrome mouse models at
postnatal day 2 indicate that this tendency is maintained and the
magnitude of integration between the facial skeleton and
neurocranium is even greater at later stages of development (data
not shown). This indicates that alteration of FGF/FGFR signaling
leads to skull dysmorphologies that could represent the combined
result of primary shape changes caused by the direct effects of the
Apert syndrome mutations and secondary shape changes triggered
by the indirect effect of increased covariation between the face and
the neurocranium.
The anatomical separation of the skull into facial skeleton and
neurocranium mainly reveals functional interactions within regions
(i.e. the facial skeletal morphology develops and responds to visual,
olfactory and masticatory soft tissues and functions, whereas the
neurocranium mainly responds to CNS growth and vascularization
while functioning to protect the brain). Our results indicate that the
face and the neurocranium have a simply structured covariation
pattern that can be summarized into a single pair of PLS axes that
account for more than 90% of the total covariation (Table 1) that is
shared across Fgfr2
+/S252W and Fgfr2
+/P253R mutant mice and their
non-mutant littermates (Fig. 2). As expected for modular structures
[12], integration within the facial skeleton and within the
neurocranium is higher than integration between regions (Fig. 4).
However, a priori hypothesis testing that face and neurocranium
represent two different modules was not supported by our analysis
(Fig. S1 and Supporting Information S1).
Covariation analyses of skull regions defined by alternative
developmental criteria to partition the skull, such as the embryo-
logical origin(neural crest/mesoderm derived bones)or the mode of
ossification (endochondral/intramembranous ossification) did not
revealanysignificant effects ofFGF/FGFR alterationon patterns of
skull morphological integration in Fgfr2
+/S252W and Fgfr2
+/P253R
Apert syndrome mouse models (Supporting Information S2).
Molecular underpinnings of increased skull MI in Apert
syndrome mouse models
The specific molecular interactions that lead to increased skull
MI within and between the facial skeleton and the neurocranium
of Fgfr2
+/S252W and Fgfr2
+/P253R mice (Fig. 4) are difficult to predict
because FGF/FGFR signaling can be directly and indirectly up-
and down regulated by other interacting signaling pathways (i.e.,
BMP, MAPK, Wnt, Ihh, Shh) [1]. However, knowledge of the
overall effect of Fgfr2 mutations on FGF/FGFR signaling can
provide some clues and help to formulate hypotheses. Our Apert
syndrome mouse models are heterozygotes, so cells expressing
Fgfr2 receptors have both normal and mutant receptors, the latter
of which lead to aberrant Fgfr2 activation by modifying ligand
affinity and specificity [5]. If mutant receptors are homogeneously
distributed throughout the facial and neurocranial regions of the
skulls of Apert syndrome mouse models, a net increase in the
length and strength of Fgfr2 signaling may be responsible for the
increased level of integration within the face, within the
neurocranium, as well as between the face and the neurocranium.
Overall, the two Fgfr2 Apert syndrome mutations produce
similar morphological effects [6–9]. However, significant localized
differences have been reported between the two models and the
S252W mutation has been associated with more severe skull
dysmorphologies [9]. Here we provide an additional piece of
evidence of the difference in the effects of the two mutations on
skull development, showing that the S252W mutation increases
the range of covariation (Fig. 2A, B) and the magnitude of
integration within and between the facial skeleton and the
neurocranium (Fig. 4). Since each mutation alters the Fgfr2
receptor differently [33–36], morphological differences between
Fgfr2
+/S252W and Fgfr2
+/P253R Apert syndrome mouse models may
stem from differential affinity of the mutated receptors for specific
ligands [35]. In fact, the distinct nature of the gain of function
contacts mediated by the S252W and P253R mutations has been
proposed to reflect the phenotypic variability between the two
mutation subsets of Apert syndrome patients and mice [34–36].
Differences in the ligand binding between the two Fgfr2 mutations
and specificity of their gain of function in particular tissues might
also underlie the different effects on range of covariation and the
magnitude of integration between and within the face and the
neurocranium demonstrated here. For instance, the increased
affinity of the S252W mutation for Fgf2, which at E14.5 is widely
Figure 4. Comparison of MI within and between facial skeleton
and neurocranium across Apert syndrome mouse models and
non-mutant littermates. Bar graphs with standard deviation error
bars comparing the distribution of the integration index (EV, Eigenvalue
variance standardized by group variance*10
5) within the face (white
bars), within the neurocranium (dark grey bars) and between the face
and the neurocranium (light grey bars).
doi:10.1371/journal.pone.0026425.g004
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facial bone and limbs (www.genepaint.org), may explain why the
most intense dysmorphic effects are concentrated on the face and
why overall integration between the face and the neurocranium is
more increased in Fgfr2
+/S252W mutant mice (Fig. 4). In fact,
Fgfr2
+/S252W mutant mice show the most substantial increase of
integration within the face and display the palatal dysmorpholo-
gies that are more frequently associated with Apert syndrome
patients carrying the S252W mutation [9]. In comparison to the
S252W mutation that enhances signaling with a limited subset of
Fgfs, the P253R mutation enhances signaling with many Fgfs [35]
and one hypothesis is that the P253R mutation may respond to
many more signals that can have overlapping, redundant, and/or
counteracting effects, resulting in a more moderate increase of MI.
Conclusions
In FGFR1-3 related craniosynostosis syndromes, balance
alteration of cell biological activities regulated by FGF/FGFR
signaling causes changes in molecular spatio-temporal dynamics
leading to anomalies in cellular and developmental processes that
change the shape of skull bones, but the structure of the osseous
tissue remains within normal limits. Here we show that besides
morphological dysmorphologies (premature suture fusion, midfa-
cial hypoplasia, and cleft palate), Apert syndrome Fgfr2 mutations
affect morphological integration patterns within the skull by
increasing its magnitude. As FGFs and their receptors are
expressed in other developing tissues such as peripheral nerves,
the CNS and vasculature, it is likely that FGF/FGFR signaling
also contributes to the integration within each of these structures,
as well as between them during development of the head. We
propose that cell communication and cell interactions that are
influenced by FGF/FGFR signaling underlie basic developmental
processes coordinating head morphogenesis and contribute to the
coordinated growth and development of a functional and
operational head.
Supporting Information
Figure S1 Histograms of the distribution of the RV coefficients
computed after all possible random partitions of equally sized
subsets of landmarks (K=8). Arrows indicate the RV coefficient
for the actual hypothesis tested (modularity of face and
neurocranium) in each grouping of samples: Fgfr2
+/+ non-mutant
mice of both models (white); Fgfr2
+/S252W and Fgfr2
+/P253R mutant
mice (black); Fgfr2
+/S252W (purple) and Fgfr2
+/P253R (yellow) Apert
mice.
(TIF)
Table S1 Anatomical definitions of 16 three-dimensional skull
landmarks collected from mCT images of mice at P0. Landmarks
are illustrated in Fig. 1.
(DOC)
Supporting Information S1 Modularity test: facial and
neurocranial skeleton within the skull of Fgfr2
+/S252W and Fgfr2
+/
P253R Apert syndrome mouse models and their non-mutant
littermates.
(DOC)
Supporting Information S2 Morphological integration pat-
terns between 1) neural crest/mesoderm derived bones and 2)
endochondral/intramembranous bones.
(DOC)
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